As Opioid Epidemic Rages, Complementary Health Approaches to Pain Gain Traction

By |2016-11-03T15:24:34-07:00November 3rd, 2016|We Know Psychiatry|

A recent review of clinical evidence published in Mayo Clinic Proceedings by National Institutes of Health (NIH) researchers suggests that complementary health techniques have a legitimate place in a physician’s pain relief toolkit—welcome news as health care professionals and agencies grapple with the crisis of opioid abuse. Researchers led by Richard [...]

Facebook Posts Used to Manage Mental Health Disorders

By |2016-10-28T18:35:54-07:00October 28th, 2016|We Know Psychiatry|

Cambridge researchers believe Facebook status updates, “likes” and even photos, could help professionals better understand mental health disorders. Investigators believe that with the right ethical safeguards, social networks may even be used in the future to provide support and interventions — particularly among young people. Over a billion people worldwide [...]

Psychopharmacology Bulletin: 36 Articles Uploaded to PubMed

By |2016-10-14T17:07:53-07:00October 14th, 2016|We Know Psychiatry|

psychopharmacology-bulletin-36-articles-uploaded-to-pubmed   October 13, 2016. Los Angeles CA Contact: James La Rossa Jr., or Michael E. Thase, MD, at 310.374.1300 www.medworksmedia.com Psychopharmacology Bulletin 36 Articles Uploaded to PubMed Replica Journal Issue Available for Readers Zonisamide for Bipolar Disorder, Mania or Mixed States: A Randomized, Double Blind, Placebo-Controlled Adjunctive Trial Deborah [...]

Improving Access to Effective Care for People With Mental Health and Substance Use Disorders

By |2016-09-26T22:45:24-07:00September 26th, 2016|We Know Psychiatry|

By James Knickman, PhD, Ranga Krishnan, MB, ChB, and Harold Pincus, MD   The United States needs to do more to help improve the outcomes of people with mental health disorders, substance use disorders, or both. In 2014, approximately 18% of US adults experienced some form of mental health disorder and 8% had a substance use disorder.1 Mental [...]

Treatment of Adult Depression in the United States

By |2016-09-03T17:29:30-07:00September 3rd, 2016|We Know Psychiatry|

Original Investigation ABSTRACT Importance Despite recent increased use of antidepressants in the United States, concerns persist that many adults with depression do not receive treatment, whereas others receive treatments that do not match their level of illness severity. Objective To characterize the treatment of adult depression in the United States. [...]

Growing Older AND Happier

By |2016-08-31T15:23:34-07:00August 31st, 2016|We Know Psychiatry|

Older people tend to be happier than younger people, and their happiness increases with age, according to psychiatric researchers who studied 1,546 people aged 21 to 99. Though the older group reported more cognitive and physical decline, this group was associated with more satisfaction, happiness and well-being, and less anxiety, [...]

Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder A Randomized Clinical Trial

By |2016-08-27T16:42:44-07:00August 27th, 2016|We Know Psychiatry|

By Evdokia Anagnostou, MD1; Michael G. Aman, PhD; Benjamin L. Handen, PhD, et al. ABSTRACT Importance Atypical antipsychotic medications are indicated for the treatment of irritability and agitation symptoms in children with autism spectrum disorder (ASD). Unfortunately, these medications are associated with weight gain and metabolic complications that are especially [...]

Atypical Antipsychotic-Induced Weight Gain in Children and Adolescents: Sometimes Less Is More

By |2016-08-27T16:35:02-07:00August 27th, 2016|We Know Psychiatry|

EDITORIAL By Christopher J. McDougle, MD In this issue of JAMA Psychiatry, Anagnostou et al1 present results of a double-blind, placebo-controlled study of metformin for weight management in children and adolescents with autism spectrum disorder (ASD) treated with an atypical antipsychotic medication. Metformin was significantly more efficacious than the placebo [...]

New Issue of Psychopharmacology Bulletin: Paliperidone, Asenapine, Dextromethorphan, and More

By |2016-08-19T15:37:36-07:00August 19th, 2016|We Know Psychiatry|

https://medworksmedia.com/product-category/psychopharmacology-bulletin/psychopharmacology-46-2/ For Immediate Release August 18, 2016. Los Angeles CA Contact: James La Rossa Jr., or Michael E. Thase, MD, at 310.374.1300 New Issue of Psychopharmacology Bulletin ORIGINAL RESEARCH An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder Patricia Pilkinton, Carlos Berry, Seth Norrholm, [...]

Go to Top